Key Takeaways: - A synbiotic preparation (SIM01) has shown promising results for alleviating symptoms of post-acute COVID-19 syndrome (PACS) in a double-blind, randomized controlled trial in Hong Kong. - Patients receiving SIM01 experienced greater alleviation of fatigue, memory loss, difficulty in concentration, gastrointestinal upset, and general unwellness compared to the placebo group. - SIM01 led to improved gut microbiota composition, reduced antimicrobial resistant genes, and favorable changes in microbiome functions.
Summary: The study investigated a synbiotic preparation, SIM01, for alleviating symptoms of post-acute COVID-19 syndrome (PACS) in a randomized controlled trial. The trial, conducted in Hong Kong, involved patients suffering from PACS symptoms following SARS-CoV-2 infection. Patients receiving SIM01 showed significant alleviation of symptoms, such as fatigue, memory…
